American Well ROE 2019-2025 | AMWL
Current and historical return on equity (ROE) values for American Well (AMWL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| American Well ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $-0.11B | $0.27B | -38.51% |
| 2025-06-30 | $-0.13B | $0.30B | -39.46% |
| 2025-03-31 | $-0.16B | $0.31B | -45.93% |
| 2024-12-31 | $-0.21B | $0.32B | -56.71% |
| 2024-09-30 | $-0.21B | $0.35B | -52.48% |
| 2024-06-30 | $-0.31B | $0.38B | -68.18% |
| 2024-03-31 | $-0.35B | $0.42B | -67.54% |
| 2023-12-31 | $-0.68B | $0.48B | -114.50% |
| 2023-09-30 | $-0.69B | $0.52B | -92.78% |
| 2023-06-30 | $-0.62B | $0.64B | -70.03% |
| 2023-03-31 | $-0.60B | $0.71B | -58.86% |
| 2022-12-31 | $-0.27B | $1.08B | -23.69% |
| 2022-09-30 | $-0.26B | $1.11B | -21.71% |
| 2022-06-30 | $-0.24B | $1.16B | -19.31% |
| 2022-03-31 | $-0.21B | $1.21B | -16.69% |
| 2021-12-31 | $-0.18B | $1.26B | -14.17% |
| 2021-09-30 | $-0.18B | $1.30B | -14.38% |
| 2021-06-30 | $-0.19B | $1.19B | -15.35% |
| 2021-03-31 | $-0.24B | $1.22B | -25.44% |
| 2020-12-31 | $-0.22B | $1.25B | -35.23% |
| 2020-06-30 | $-0.14B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.068B | $0.254B |
| American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.08 |
| Hims & Hers Health (HIMS) | United States | $9.340B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.882B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.377B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.605B | 8.43 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.565B | 113.67 |
| Butterfly Network (BFLY) | United States | $0.563B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |